Addressing the critical gap: conscious sedation for pediatric oncology patients in LMICs.

Conscious Sedation LMICs Need of Training Treatment Delays

Journal

Discover oncology
ISSN: 2730-6011
Titre abrégé: Discov Oncol
Pays: United States
ID NLM: 101775142

Informations de publication

Date de publication:
08 Sep 2024
Historique:
received: 28 05 2024
accepted: 30 07 2024
medline: 8 9 2024
pubmed: 8 9 2024
entrez: 8 9 2024
Statut: epublish

Résumé

Most newly diagnosed pediatric cancer patients reside in LMICs. These countries face challenges in providing quality treatment, particularly with procedures requiring stillness or causing pain. Conscious sedation (CS) is underutilized in LMICs due, causing treatment delays and adverse outcomes. Advocacy for CS teams, training, and policy support is essential to improve outcomes.

Identifiants

pubmed: 39244740
doi: 10.1007/s12672-024-01209-4
pii: 10.1007/s12672-024-01209-4
doi:

Types de publication

Letter

Langues

eng

Pagination

415

Informations de copyright

© 2024. The Author(s).

Références

Force LM, Abdollahpour I, Advani SM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20(9):1211–25.
doi: 10.1016/S1470-2045(19)30339-0
Koh JL, Palermo T. Conscious sedation: reality or myth? Pediatr Rev. 2007;28(7):243–8.
doi: 10.1542/pir.28.7.243 pubmed: 17601936
Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020. https://doi.org/10.1136/bmj.m4087 .
doi: 10.1136/bmj.m4087 pubmed: 33148535
Majeed A, Wright T, Guo B, Arora RS, Lam CG, Martiniuk AL. The global impact of COVID-19 on childhood cancer outcomes and care delivery-a systematic review. Front Oncol. 2022;12: 869752.
doi: 10.3389/fonc.2022.869752 pubmed: 35463381 pmcid: 9023072
Leelataweedwud P, Vann WF Jr. Adverse events and outcomes of conscious sedation for pediatric patients: study of an oral sedation regimen. J Am Dent Assoc. 2001;132(11):1531–9.
doi: 10.14219/jada.archive.2001.0086 pubmed: 11811136

Auteurs

Syed Ibrahim Bukhari (SI)

Department of Oncology, Aga Khan University, Karachi, Pakistan.

Gashaw Arega (G)

Division of Hematology Oncology, Department of Pediatrics & Child Health, Addis Ababa University, Addis Ababa, Ethiopia. gashaw.arega@aau.edu.et.

Sadaf Altaf (S)

Department of Oncology, Aga Khan University, Karachi, Pakistan.

Classifications MeSH